Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
Title:
Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
Author:
Chapman, P.B. Robert, C. Larkin, J. Haanen, J.B. Ribas, A. Hogg, D. Hamid, O. Ascierto, P.A. Testori, A. Lorigan, P.C. Dummer, R. Sosman, J.A. Flaherty, K.T. Chang, I. Coleman, S. Caro, I. Hauschild, A. McArthur, G.A.